Post by Ratio Therapeutics

Our CSO John Babich, Ph.D., sat down with David E. Williams on the CareTalk Podcast: Healthcare. Unfiltered. to talk about where targeted radiotherapeutics are headed next. He discussed how Ratio's Trillium™ platform fine-tunes a molecule's pharmacokinetics to maximize tumor uptake, why Macropa™ is such an effective chelator for actinium-225, and why the Ac-225 supply picture looks far more promising than it did five years ago — thanks to scaling efforts from groups like TerraPower Isotopes, PanTera, and Niowave. Listen to the full conversation: https://lnkd.in/eYWMki-m #Radiopharmaceuticals #radiopharma #PrecisionMedicine #CancerResearch #Biotech #Innovation